Cell Therapy – RepliCel long anticipated RCH-01 cell therapy hair regeneration treatment encountered a roadblock. In December 2021, RepliCel officially announced termination of its license agreement with cosmeticeutical giant Shiseido due to ongoing dispute. There is no word as to how this may unfold and whether their RCH-01 hair regeneration treatment for androgenetic alopecia or pattern baldness will be available in the near future, if at all.

Click RepliCel terminates agreement with Shiseido on its RCH-01 hair regeneration product for details.